Module 321

Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
General Properties
Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module.
Num gene sets: 3
Num genes: 113 (see 886 additional genes for this module)
Num experiments: 492 (199 induced, 293 repressed)
Parent module: None
Children modules: None


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Gene sets
Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates.
Perou00 28
Perou00 43
Ross00 50


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched clinical annotations
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched.
Clinical annotation Category P-value Hits Hits(%) Module hits in category Arrays in annotation Arrays
CNS tissue, cancer or cell line (Neuro tumors*) Neuro tumors* 1.0e-24 53 18.1 292 85 1945
CNS cancer or cell line (Neuro tumors*) Neuro tumors* 5.1e-23 50 17.1 292 81 1945
CNS tumor (Neuro tumors*) Neuro tumors* 5.1e-23 50 17.1 292 81 1945
Cancer and cell line (Neuro tumors*) Neuro tumors* 2.4e-21 50 17.1 292 86 1945
Cancer (Neuro tumors*) Neuro tumors* 2.4e-21 50 17.1 292 86 1945
Hematologic cancer and cell line (Stimulated PBMC) Stimulated PBMC 6.4e-21 23 92 25 30 182
Macrophages (Stimulated PBMC) Stimulated PBMC 6.4e-21 23 92 25 30 182
Lung carcinoid (Lung cancer) Lung cancer 1.8e-10 15 37.5 40 20 276
Cancer and cell line (Liver cancer) Liver cancer 4.7e-10 38 100 38 126 207
Cell line (NCI60*) NCI60* 2.0e-09 47 16.0 292 135 1945
Cancer and cell line (NCI60*) NCI60* 4.7e-09 47 16.0 292 138 1945
Cell line (NCI60*) NCI60* 1.2e-08 36 18.0 199 135 1945
Hematologic samples and cell lines (Various tumors) Various tumors 2.3e-08 18 72 25 37 154
Hematologic samples (Various tumors) Various tumors 2.3e-08 18 72 25 37 154
Cancer and cell line (NCI60*) NCI60* 2.4e-08 36 18.0 199 138 1945
Hematologic cancer and cell line (NCI60) NCI60 8.2e-08 14 29.1 48 14 139
Hematologic samples and cell lines (NCI60) NCI60 8.2e-08 14 29.1 48 14 139
Leukemia cell line (NCI60) NCI60 8.2e-08 14 29.1 48 14 139
Cancer (Liver cancer) Liver cancer 1.0e-06 34 89.4 38 115 207
Liver tissue, cancer or cell line (Liver cancer*) Liver cancer* 5.6e-06 40 20.1 199 197 1945
Hematologic cancer and cell line (Various tumors) Various tumors 1.1e-05 14 56 25 31 154
Hematologic cancer (Various tumors) Various tumors 1.1e-05 14 56 25 31 154
Primary blood mononuclear cells (Various tumors) Various tumors 1.1e-05 14 56 25 31 154
B. petrussis A2 stimulated immune cells (Stimulated PBMC) Stimulated PBMC 1.7e-05 5 27.7 18 5 144
Lymphocytes (Various tumors) Various tumors 2.0e-05 13 52 25 28 154
Monocytes (Various tumors) Various tumors 2.0e-05 13 52 25 28 154
Fast doubling (20-40) cell lines (NCI60) NCI60 5.5e-05 43 93.4 46 90 122
Liver tissue (Liver cancer*) Liver cancer* 6.3e-05 36 18.0 199 187 1945
Breast cancer cell line (Breast cancer) Breast cancer 6.4e-05 9 40.9 22 17 152
Small cell lung cancer (Lung cancer) Lung cancer 7.0e-05 7 17.5 40 10 276
Cell line (Breast cancer) Breast cancer 7.5e-05 12 54.5 22 30 152
B cells (Various tumors) Various tumors 9.3e-05 11 44 25 23 154
Atypical teratoid/rhabdoid tumour - CNS and other origin (Neuro tumors) Neuro tumors 0.0001 6 54.5 11 10 90
Acute lymphocytic leukemia (Leukemia) Leukemia 0.0001 20 100 20 99 149
Hematologic cancer and cell line (Stimulated immune*) Stimulated immune* 0.0001 15 7.5 199 53 1945
Hematologic samples and cell lines (Stimulated immune*) Stimulated immune* 0.0001 15 7.5 199 53 1945
Macrophages (Stimulated immune*) Stimulated immune* 0.0001 15 7.5 199 53 1945
Monocytes (Stimulated immune*) Stimulated immune* 0.0001 15 7.5 199 53 1945
Female hormonal cancer cell line (Breast cancer) Breast cancer 0.0001 8 36.3 22 15 152
Metastasis (Liver cancer) Liver cancer 0.0003 7 18.4 38 10 207
Mesenchemal cell line (Breast cancer) Breast cancer 0.0003 4 18.1 22 4 152
Large cell lung cancer (Lung cancer) Lung cancer 0.0004 3 21.4 14 4 276
Lymphoma (B lymphoma) B lymphoma 0.0004 16 64 25 77 245


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched GO annotations
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column).
GO annotation P-value Hits Hits(%) Module genes Genes in annotation Genes
cell-matrix adhesion 0.0001 5 6.1 81 29 4566


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Visual display
Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets.
You can also view the images within GeneXPress by loading the module gxp file file.
Note: Since there are 492 experiments, this image does not display the individual experiment names, but rather condenses each experiment to a single pixel without displaying its name. You can fully view the image for this module within GeneXPress, by loading any of the four files mentioned in the line above
 
 





 >4x